Your Idea to Infinity Partners

If you’re doing the zero-to-one grind, having capital plus execution muscle really pushes the friction out. With AI-native agent-platform like Realfast, we were going up against tech debt, enterprise inertia and high expectations. Aakash and the team at DeVC became our co-pilots: intros, product-ops feedback, even board-level thinking.

They understood the nuance of voice-AI in patient workflows, helped open doors to early trials, and were there during raw hire decisions and go-to-market pivots. DeVC treated us like a provider-ops partner, not a health-tech bet.

The DeVC team moved at our pace and helped us think about enterprise code health frameworks, not just features. That clarity and alignment made a real difference.

DeVC’s backing felt less like a cheque, and more like strategic horsepower. From our first conversation, the team challenged our assumptions around global compliance and helped us focus the product roadmap.

Zero-to-one is a product and velocity game: and most founders benefit hugely from having someone in the room who’s shipped at scale. DeVC’s model is rare — where operators aren’t just advising,  we’re co-owning the journey, sharpening decisions and participating in the upside.

Most early-stage investors chase themes, DeVC actually studies ground reality. It creates a powerful advantage: founders get strategic clarity early, and we get to back and shape businesses with stronger fundamentals from day one.

Having built in healthcare for nearly two decades, I’ve seen how lonely and high-stakes the zero-to-one phase can be. That’s what I like about the DeVC team:  they don’t romanticise early-stage building. They get into the weeds on GTM, talent, regulatory nuance and founder psychology — the kind of partner I wish I had during my own early scaling years.